Pharma Pulse 1/9/25: Digital Transformation's Impact on 2025, Rural Women Experience Worse Menopausal Symptoms/Limited Resources & more

The Impact of Digital Transformation in 2025

According to a new report from Deloitte, the life sciences industry will have a transformative year. The industry faces renewed scrutiny over pricing and access, but new technologies are providing new solutions. Pete Lyons, vice and US life sciences sector leader at Deloitte Pete Lyons discusses the report’s findings and other key trends for the coming year.

Rural Women Experience Worse Menopausal Symptoms and Limited Resources, Study Finds

A new, first-of-its-kind study found that these symptoms occur particularly during the late menopause transition and post-menopause.

Amazon Plans to Invest at Least $11 Billion in Cloud and AI Infrastructure in Georgia

The investment aims to meet the increased demand for advanced cloud infrastructure and compute power, driven by generative AI, it said. Amazon has invested $18.5 billion in the state since 2010.

Celmatix Launches Novel Endometriosis Drug Program

Celmatix Therapeutics announced its latest drug program, a novel Jun-N-terminal kinase (JNK) inhibitor that targets pain and inflammation. The therapeutic drug candidate, developed using the DNA-Encoded Chemistry Technology (DEC-Tec) platform at the Center for Drug Discovery, Baylor College of Medicine (BCM), aims to address a critical unmet need in first-line treatments for a range of women’s health indications, starting with endometriosis and potentially extending to Polycystic Ovary Syndrome (PCOS) and ovarian aging.

The Axia Institute - Michigan State University on LinkedIn

As innovators, we're already looking beyond 2025. We're not stopping with meeting regulatory requirements that provide end-to-end visibility of pharmaceutical drugs. In the future, using RFID and NFC technologies can provide patients with valuable information about their medication, hospitals with a more secure supply chain, and manufacturers with a stronger competitive advantage. Hear more about the future of RFID in the pharmaceutical supply chain in the last segment of "Peer Exchange: The Future of RFID and Supply Chain Management" with Pharmaceutical Commerce Magazine, featuring Axia's Bahar Aliakbarian, PhD.

#RFID #healthcare #traceability

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs